Workplace and clinical toxicology screenings often utilize assays produced by Abbott Laboratories, a global healthcare company. These assays detect the presence or absence of specific substances, including drugs of abuse, therapeutic medications, and their metabolites, in biological samples like urine, blood, or saliva. A typical report from such a screening identifies the substance tested for, the sample type, the testing methodology, and the result, which may be positive, negative, or inconclusive.
Accurate and timely laboratory data plays a crucial role in various contexts. For employers, these screenings support safe work environments and compliance with regulations. In healthcare settings, results inform patient care decisions, monitor medication adherence, and contribute to diagnoses. Abbott’s long history of developing diagnostic tools has established its prominence in this field, providing reliable data that aids professionals in making informed decisions related to health and safety. The evolution of testing technologies toward greater sensitivity and specificity continues to enhance the reliability and value of these screenings.
